Evidence map›Paper›PMID 28924151›Full record

ArticleScientific reports2017

DNA Methylomes Reveal Biological Networks Involved in Human Eye Development, Functions and Associated Disorders.

María Berdasco, Antonio Gómez, Marcos J Rubio, Jaume Català-Mora, Vicente Zanón-Moreno, Miguel Lopez, Cristina Hernández, Shigeo Yoshida, Takahito Nakama, Keijiro Ishikawa and 17 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 53 citations in OpenAlex.

  1. Global epigenetic immunohistochemical markers reveal developmental connections of distinct cell types during fetal development.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. CD44, ACAN, PLVAP, and HBEGF Emerged as Potential Biomarkers in Diabetic Retinopathy.Diabetes, metabolic syndrome and obesity : targets and therapy · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Diabetic Retinopathy and Cardiovascular Disease: A Literature Review.Diabetes, metabolic syndrome and obesity : targets and therapy · 2023
    Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. NSUN2-mediated RNA mEpigenetics · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 11 institutions in 5 countries.

María BerdascoCancer Epigenetics Group; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain. mberdasco@idibell.cat.
Antonio GómezCancer Epigenetics Group; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.
Marcos J RubioDepartment of Ophthalmology, Bellvitge University Hospital, L'Hospitalet de Llobregat, Catalonia, Spain.ORCID 0000-0002-7072-9855
Jaume Català-MoraHospital Sant Joan de Deu, Esplugues de Llobregat, Barcelona, Catalonia, Spain.ORCID 0000-0003-2152-8579
Vicente Zanón-MorenoUnidad de Epidemiología Molecular y Genética del Departamento de Medicina Preventiva y Salud Pública de la Facultad de Medicina y Odontología y Centro de Investigación en Red Fisiopatología de la Obesidad y Nutrición (CIBERobn), Universidad de Valencia, Valencia, Spain.ORCID 0000-0003-1179-1592
Miguel LopezCancer Epigenetics Group; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.
Cristina HernándezDiabetes and Metabolism Research Unit, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, Catalonia, Spain.
Shigeo YoshidaDepartment of Ophthalmology, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Takahito NakamaDepartment of Ophthalmology, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Keijiro IshikawaDepartment of Ophthalmology, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Tatsuro IshibashiDepartment of Ophthalmology, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Amina M BoubekeurFaculty of Life and Natural Science, Department of Applied Molecular Genetics, Laboratory of Medical Genetics, University of Science and Technology of Oran, Mohamed Boudiaf, Oran, Algeria.
Lotfi LouhibiFaculty of Life and Natural Science, Department of Applied Molecular Genetics, Laboratory of Medical Genetics, University of Science and Technology of Oran, Mohamed Boudiaf, Oran, Algeria.
Miguel A PujanaCancer Systems Biology Group; Program Against Cancer Therapeutic Resistance (ProCURE); Catalan Institute of Oncology (ICO), Bellvitge Biomedical Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.
Sergi SayolsCancer Epigenetics Group; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.ORCID 0000-0002-3877-4170
Fernando SetienCancer Epigenetics Group; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.
Dolores CorellaUnidad de Epidemiología Molecular y Genética del Departamento de Medicina Preventiva y Salud Pública de la Facultad de Medicina y Odontología y Centro de Investigación en Red Fisiopatología de la Obesidad y Nutrición (CIBERobn), Universidad de Valencia, Valencia, Spain.ORCID 0000-0002-2366-4104
Carmen de TorresHospital Sant Joan de Deu, Esplugues de Llobregat, Barcelona, Catalonia, Spain.
Andreu PararedaHospital Sant Joan de Deu, Esplugues de Llobregat, Barcelona, Catalonia, Spain.
Jaume MoraHospital Sant Joan de Deu, Esplugues de Llobregat, Barcelona, Catalonia, Spain.ORCID 0000-0003-2152-8579
Ling ZhaoShiley Eye Institute and Institute for Genomic Medicine, University of California, San Diego, La Jolla, United States.
Kang ZhangShiley Eye Institute and Institute for Genomic Medicine, University of California, San Diego, La Jolla, United States.
Matilde E LleonartBiomedical Research in Cancer Stem Cells Group, Vall d'Hebron Research Institute (VHIR), Barcelona, Catalonia, Spain.
Javier AlonsoUnidad de Tumores Sólidos Infantiles, Instituto de Investigación de Enfermedades Raras, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.ORCID 0000-0002-6287-8391
Rafael SimóDiabetes and Metabolism Research Unit, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, Catalonia, Spain.
Josep M CaminalDepartment of Ophthalmology, Bellvitge University Hospital, L'Hospitalet de Llobregat, Catalonia, Spain.
Manel EstellerCancer Epigenetics Group; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain. mesteller@idibell.cat.
Institut d'Investigació Biomédica de Bellvitge · ESHospital Sant Joan de Déu Barcelona · ESKyushu University · JPBellvitge University Hospital · ESUniversitat Autònoma de Barcelona · ESUniversitat de València · ESUniversité des Sciences et de la Technologie d'Oran Mohamed Boudiaf · DZUniversity of California San Diego · USInstitució Catalana de Recerca i Estudis Avançats · ESInstituto de Salud Carlos III · ESVall d'Hebron Institut de Recerca · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This work provides a comprehensive CpG methylation landscape of the different layers of the human eye that unveils the gene networks associated with their biological functions and how these are disrupted in common visual disorders. Herein, we firstly determined the role of CpG methylation in the regulation of ocular tissue-specification and described hypermethylation of retinal transcription factors (i.e., PAX6, RAX, SIX6) in a tissue-dependent manner. Second, we have characterized the DNA methylome of visual disorders linked to internal and external environmental factors. Main conclusions allow certifying that crucial pathways related to Wnt-MAPK signaling pathways or neuroinflammation are epigenetically controlled in the fibrotic disorders involved in retinal detachment, but results also reinforced the contribution of neurovascularization (ETS1, HES5, PRDM16) in diabetic retinopathy. Finally, we had studied the methylome in the most frequent intraocular tumors in adults and children (uveal melanoma and retinoblastoma, respectively). We observed that hypermethylation of tumor suppressor genes is a frequent event in ocular tumors, but also unmethylation is associated with tumorogenesis. Interestingly, unmethylation of the proto-oncogen RAB31 was a predictor of metastasis risk in uveal melanoma. Loss of methylation of the oncogenic mir-17-92 cluster was detected in primary tissues but also in blood from patients.

Indexed as

Diabetic RetinopathyDNA MethylationDNA, NeoplasmEpigenesis, GeneticEyeEye ProteinsGene Expression Regulation, NeoplasticMAP Kinase Signaling SystemNeoplasm ProteinsRetinal NeovascularizationAdultChildChild, PreschoolEye NeoplasmsFemaleHumansDNA, NeoplasmEye ProteinsNeoplasm Proteins

Identifiers

PMID28924151
PMCPMC5603607
OpenAlexW2754078715

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.